COMMERCIALIZING WORLD-CLASS CANCER INNOVATION
Seeding and scaling Ontario’s premiere entrepreneurial ventures for patients and the economy.
KEY SUCCESSES
Our investments have resulted in significant partnerships, clinical trials, job creation and leveraged financing for the province.
RECENT NEWS
Keep up to date on our investments and business developments in recent news stories and summaries.
-
Hamilton, Ontario startup NodeAI wins Falcons’ Fortunes 2025 for revolutionary lung cancer diagnostics using artificial intelligence
March 25, 2025 – The winning pitch at FACIT’s sold-out annual Falcons’ Fortunes pitch competition and recipient of the $100,000 Ernsting Entrepreneurship award was delivered by Dr. Waël Hanna, co-founder and Chief Medical Officer of NodeAI Diagnostics (“NodeAI”). The Hamilton, Ontario based start-up is leveraging the power of artificial intelligence to improve the speed and…
-
FACIT and OBIO® announce inaugural WeSEED cohort of women-led start-ups in joint seed capital and commercialization program
March 6, 2025 – The Women’s Synergistic Entrepreneurship and Economic Development (WeSEED) program leverages the combined, complementary capital, expertise and resources of OBIO® and FACIT. The resulting synergies provide a continuum of seamless support and lower barriers faced by women STEM leaders in accessing business training, advisory resources, networks and venture funding. Read More from…
-
Idea to Investment Podcast: How FACIT’s support propels early cancer innovations
January 17, 2025 – FACIT’s David Koehler, Director of Fund Operations, appeared on TechAlliance’s Idea to Investment podcast along with Saumik Biswas, President, CEO and Founder of Tenomix Inc. based in London, Ontario. Tenomix’s advancements exemplifies how FACIT’s continuum of commercialization programs can strategically capitalize on homegrown talent and innovations to spur promising start-ups to…
We were established by the Ontario Institute for Cancer Research (OICR) to support commercialization, technology transfer, and development activities. OICR conducts and enables world-class cancer research, filling a critical role as a pan-provincial connector of oncology researchers, resources and cancer innovation development. Together with OICR, we drive a shared vision to attract more R&D investment in Ontario and help the best oncology innovations reach the market and save lives.
FACIT is funded in part by the Government of Ontario through OICR